Literature DB >> 30949833

[Cannabis-based drugs : Don't pit clinical experience and systematic reviews against each other].

M Schmelz1, W Häuser2, E Hoch3, F Petzke4, C Sommer5.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30949833     DOI： 10.1007/s00482-018-0349-8

Source DB:  PubMed          Journal:  Schmerz        ISSN： 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  4 in total

Review 1.  Systematic reviews with meta-analysis on cannabis-based medicines for chronic pain: a methodological and political minefield.

Authors:  Winfried Häuser; Nanna B Finnerup; R Andrew Moore
Journal:  Pain       Date:  2018-10       Impact factor: 6.961

Review 2.  [Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review].

Authors:  M S Volz; B Siegmund; W Häuser
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

Review 3.  Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): A systematic review of randomized controlled trials.

Authors:  M-A Fitzcharles; C Baerwald; J Ablin; W Häuser
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

Review 4.  Cannabis-based medicines for chronic neuropathic pain in adults.

Authors:  Martin Mücke; Tudor Phillips; Lukas Radbruch; Frank Petzke; Winfried Häuser
Journal:  Cochrane Database Syst Rev       Date:  2018-03-07
  4 in total
  5 in total

Review 1.  [The use of cannabis-based drugs in pain and palliative medicine : Joint online questionnaire conducted by the Professional Association of Physicians and Psychotherapists in Pain and Palliative Medicine in Germany (BVSD), the German Pain Society, and the German Society for Pain Medicine (DGS)].

Authors:  Knud Gastmeier
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

Review 2.  [Cannabis-based medicines for chronic pain: indications, selection of drugs, effectiveness and safety : Experiences of pain physicians in Saarland].

Authors:  Patric Bialas; Beate Drescher; Sven Gottschling; Stephanie Juckenhöfel; Dieter Konietzke; Wolfgang Kuntz; Isabell Kühne-Adler; Heidi Merl-Ripplinger; Diether Preisegger; Kathrein Schneider; Manfred Strauß; Patrick Welsch; Winfried Häuser
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

3.  [Cannabis].

Authors:  Peter Cremer-Schaeffer; Winfried Häuser
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

4.  [Medicinal cannabis and cannabis-based medication: an appeal to physicians, journalists, health insurances, and politicians for their responsible handling].

Authors:  Winfried Häuser; Eva Hoch; Frank Petzke; Rainer Thomasius; Lukas Radbruch; Anil Batra; Claudia Sommer; Ursula Havemann-Reinecke
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

5.  [Cannabis medicines in pain management : Interim analysis of the survey accompanying the prescription of cannabis-based medicines in Germany with regard to pain as primarily treated symptom].

Authors:  P Cremer-Schaeffer; G Schmidt-Wolf; K Broich
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.